Skip to main content

Fiscal Wizard · Single-issue tearsheet

LABT / Jun 22, 2026 Run #7608

LABT

Lakewood-Amedex Biotherapeutics, Inc.

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida.

Composite verdict

F 0.4 / 100
Bearish setup · Mean Reversion 7 drivers · 2 gates blocking
  • Stochastic Cross
  • SuperTrend
  • Engulfing
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 552nd of 598 in Biotechnology

rescore-sweep
Technical synthesis
Bull 0%Evidence: High · 11 signals100% Bear
Momentum Bearish 35Mean-reversion Bearish 17

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes from

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

0.0 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Greenblatt EY 75
Return on Assets 0
Free Cash Flow Yield 0
Asset Turnover 25

Technicals Bearish

0.8 / 100

Bearish setup leads (Stochastic Cross, SuperTrend, Engulfing); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Stochastic Cross 14
SuperTrend 16
Declining Volume 17

Risk Gates

2 blocking 3 caution

2 guards active, 15 signals gated.

Altman Z-Score Blocking

Bottom-band Altman Z blocks bullish signals — distress risk.

Debt-to-Assets Blocking

High debt-to-assets blocks bullish signals — balance-sheet leverage risk.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for LABT.